Label Image (Lbl500905553)
Tamsulosin Hydrochloride Capsule
Product Images NDC 50090-5553
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 50090-5553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)
Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)
The text relates to a figure (Figure 2A) showing the mean change from baseline in the Total AUA Symptom Score (ranging from 0 to 35) for Study 1. The figure includes two treatment groups: one group received -OO-0-08mg_A and another group received A -A04my_O30 placebo. The duration of treatment (in weeks) is also shown on the figure.*
Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)
The text describes a figure (2B) showing the mean change from baseline in a Total AUA Symptom Score on a scale from 0 to 35 for three treatments: O=0O—0-08mg LNt, 0.4mg, and placebo. The duration of treatment was measured in weeks, and the figure shows data points at weeks 0, 1, 2, 5, 9, 13, and LOCF.*
Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
This is a presentation of the mean increase in peak urine flow rate in mL/sec of Study 1. There are three categories of treatment represented in the graph as 0.08mg, 2x0.4mg, and Placebo. The duration of the treatment in weeks is shown on the bottom x-axis. The top x-axis shows the logarithmic scale of weeks. The y-axis denotes the mean change in urine flow rate in mL/sec. The sample sizes (n) are also given for each treatment category.*
Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
The text is describing a figure titled "Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2" displaying treatment and duration of treatment (in weeks) on the x-axis and the mean increase in peak urine flow rate (in mL/Sec) on the y-axis. It is not possible to determine the exact values without a visual representation of the figure.*
Chemical Structure (Tamsulosin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
